School Partnered Collaborative Care (SPACE) Intervention for Children With Type 1 Diabetes
Launched by UNIVERSITY OF PITTSBURGH · May 14, 2024
Trial Information
Current as of September 18, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This is a small, early-phase study (a pilot) to see if a school-based teamwork approach called SPACE can be put into practice for children with type 1 diabetes. In this trial, school districts are randomly chosen to start SPACE right away or to continue with usual school and clinic care (with monthly phone check-ins). The SPACE program involves four monthly virtual meetings that bring together the child, the school nurse, and a diabetes care and education specialist to make a shared plan, review glucose records, and set ongoing goals. The idea is to learn whether this school-and-provider collaboration is feasible and something families and school staff find acceptable.
If your child is eligible, they would be ages 5 to 12 with type 1 diabetes for at least 6 months, attend a participating school, receive daily help from their school nurse, and be managed by the Children’s Hospital of Pittsburgh Diabetes center, and able to participate in English. Exclusions include children who have certain developmental or neuropsychiatric conditions that would make participation hard, or those who already manage their diabetes completely independently at school. Participants in the SPACE group will have four monthly virtual visits; those in the control group will have four monthly phone calls while continuing usual care. The study will collect surveys from parents and school nurses, plus data from glucose devices and health records, to measure feasibility, acceptability, and other implementation outcomes, with results expected around 2027.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of type 1 diabetes for at least 6 months
- • Attend school in one of the partnered school districts
- • Receive daily oversight from the school nurse for their diabetes
- • Managed by the Children's Hospital of Pittsburgh Diabetes center
- • Able to participate in English
- Exclusion Criteria:
- • Child has developmental delay or neuropsychiatric disorder which would preclude their participation in their diabetes care and/or completion of study questionnaires
- • Child is completely independent in diabetes care in school
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Patients applied
Trial Officials
Christine A March, MD
Principal Investigator
Univeristy of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported